Announcements Trials
Browse Landscape

Phase

Phase 2 12Phase NA 5Phase 4 3Phase 3 2Phase 1/2 2

Status

Terminated 1Completed 1

Sponsor Class

INDUSTRY 8OTHER 2NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 1Breast 1

Conditions

Breast Neoplasms 320Leukemia, Myeloid, Acute 266Multiple Myeloma 227Carcinoma, Non-Small-Cell Lung 224Prostatic Neoplasms 202Neoplasms 196Lymphoma 191Colorectal Neoplasms 184Melanoma 179Leukemia 170Recurrence 164Pancreatic Neoplasms 163Precursor Cell Lymphoblastic Leukemia-Lymphoma 160Lung Neoplasms 150Glioblastoma 134Neoplasm Metastasis 132Lymphoma, Non-Hodgkin 128Ovarian Neoplasms 123Leukemia, Lymphocytic, Chronic, B-Cell 120Myelodysplastic Syndromes 117Lymphoma, Large B-Cell, Diffuse 110Lymphoma, Mantle-Cell 108Carcinoma, Hepatocellular 103Lymphoma, Follicular 99Stomach Neoplasms 96Carcinoma, Renal Cell 89Hodgkin Disease 88Brain Neoplasms 88Sarcoma 84Burkitt Lymphoma 75

Interventions

Surveys and Questionnaires 1Rituximab 1Acupuncture Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1/2 × OTHER × Bronchiolitis Obliterans Syndrome × Clear all
NCT01815346 2018-01-12

Acupuncture Chemotherapy-Induced Peripheral Neuropathy (CIPN) IRG

M.D. Anderson Cancer Center

Phase 1/2 Terminated
4 enrolled
Breast

Bronchiolitis Obliterans Syndrome, Breast Neoplasms

NCT00379587 2014-03-19

Rituximab for Prevention of Chronic GVHD

Dana-Farber Cancer Institute

Phase 1/2 Completed
65 enrolled 9 charts
Other hematologic neoplasm

Bronchiolitis Obliterans Syndrome, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡